Search

Your search keyword '"Najafi I"' showing total 155 results

Search Constraints

Start Over You searched for: Author "Najafi I" Remove constraint Author: "Najafi I"
155 results on '"Najafi I"'

Search Results

54. Renal involvement in patients with hepatitis C virus infection.

55. Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.

56. Uric acid in predicting the traumatic rhabdomyolysis induced acute kidney injury; a systematic review and meta-analysis.

57. Prevalence of Compartment Syndrome and Disseminated Intravascular Coagulation following Rhabdomyolysis; a Systematic Review and Meta-Analysis.

58. Potential of Autologous Adipose-Derived Mesenchymal Stem Cells in Peritoneal Fibrosis: A Pilot Study.

59. The Epidemiological Characteristics and Outcome of COVID-19 in Patients Undergoing Peritoneal Dialysis: A Multi-center Study in Iran.

60. Acute kidney injury following traumatic rhabdomyolysis in Kermanshah earthquake victims; A cross-sectional study.

61. Effects of soy isoflavones on serum systemic and vascular inflammation markers and oxidative stress in peritoneal dialysis patients: A randomized controlled trial.

62. Effects of soy isoflavones on serum lipids and lipoprotein (a) in peritoneal dialysis patients.

63. Effects of isoflavones on bone turnover markers in peritoneal dialysis patients: a randomized controlled trial.

64. Associations of Body Composition, Muscle Function, and Physical Activity with Mortality in Peritoneal Dialysis Patients.

65. Percutaneous biopsy of kidney; comparison between prone position and sitting position.

66. Dietary Intake and Its Related Factors in Peritoneal Dialysis Patients in Tehran, Iran.

67. Strategies for Prevention and Treatment of Peritoneal Fibrosis: A Scientometric Study.

68. Prevalence of Protein-Energy Wasting and Its Association With Cardiovascular Disease Risk Factors in Iranian Peritoneal Dialysis Patients.

69. Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety.

70. Prevalence of dynapenic obesity and sarcopenic obesity and their associations with cardiovascular disease risk factors in peritoneal dialysis patients.

71. A systematic review of preclinical studies on therapeutic potential of stem cells or stem cells products in peritoneal fibrosis.

72. Prevalence of Sarcopenia and Dynapenia and Their Determinants in Iranian Peritoneal Dialysis Patients.

73. Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients.

74. Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study.

75. Predictors of Clinical Outcomes in Hemodialysis Patients: a Multicenter Observational Study.

76. Trends of Serum Electrolyte Changes in Crush syndrome patients of Bam Earthquake; a Cross sectional Study.

77. 20-Day Trend of Serum Potassium Changes in Bam Earthquake Victims with Crush Syndrome; a Cross-sectional Study.

78. A New Experience With Encapsulating Peritoneal Sclerosis: Role of Early Intervention.

79. The Role of Scoring Systems and Urine Dipstick in Prediction of Rhabdomyolysis-induced Acute Kidney Injury: a Systematic Review.

80. The value of serum creatine kinase in predicting the risk of rhabdomyolysis-induced acute kidney injury: a systematic review and meta-analysis.

81. A Systematic Review of Iranian Experiences in Seismo-Nephrology.

82. Effects of Ginger on Serum Lipids and Lipoproteins in Peritoneal Dialysis Patients: A Randomized Controlled Trial.

83. National Profiles of Urinary Calculi: a Comparison Between Developing and Developed Worlds.

84. Serum Mannose-binding Lectin in Patients on Peritoneal Dialysis Compared With Healthy Individuals.

85. Impact of Kidney Transplantation on Biomarkers of Oxidative Stress and Inflammation.

86. Effects of ginger on serum glucose, advanced glycation end products, and inflammation in peritoneal dialysis patients.

87. Non-diabetic renal disease with or without diabetic nephropathy in type 2 diabetes: clinical predictors and outcome.

88. Seventeen years' experience of peritoneal dialysis in Iran: first official report of the Iranian peritoneal dialysis registry.

90. Prospective study of BK virus infection and nephropathy during the first year after kidney transplantation.

91. Survival analysis of Iranian patients undergoing continuous ambulatory peritoneal dialysis using cure model.

92. Accuracy of urine dipstick in the detection of patients at risk for crush-induced rhabdomyolysis and acute kidney injury.

93. Patient outcome in primary peritoneal dialysis patients versus those transferred from hemodialysis and transplantation.

94. Prevalence of chronic kidney disease and its associated risk factors: the first report from Iran using both microalbuminuria and urine sediment.

95. Association of overtime urine volume and ultrafiltration changes with patient survival in continuous ambulatory peritoneal dialysis patients.

96. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.

97. Renal function and risk factors of moderate to severe chronic kidney disease in Golestan Province, northeast of Iran.

98. Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.

99. The story of continuous ambulatory peritoneal dialysis in Iran.

100. Description of an outbreak of acute sterile peritonitis in Iran.

Catalog

Books, media, physical & digital resources